Abstract
Edible vaccines must survive digestive process and preserve the specific structure of the antigenic peptide to elicit effective immune response. The stability of a protein to digestive process can be predicted by subjecting it to the in vitro assay with simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). Here, we describe the protocol of producing and using chimeric Cucumber mosaic virus (CMV) displaying Hepatitis C virus (HCV) derived peptide (R9) in double copy as an oral vaccine. Its stability after treatment with SGF and SIF and the preservation of the antigenic properties were verified by SDS-PAGE and immuno western blot techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Takagi K, Teshima R, Okunuki H, Sawada J (2003) Comparative study of in vitro digestibility of food protein and effect of preheating on the digestion. Biol Pharm Bull 26(7): 969–973
Huang YY, Liu GM, Cai QF et al (2010) Stability of major allergen tropomyosin and other food proteins of mud crab (Scylla serrata) by in vitro gastrointestinal digestion. Food Chemical Toxicol 48:1196–1201
Rae CS, Khor IW, Wang Q et al (2005) Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 343:224–235
Nuzzaci M, Vitti A, Condelli V et al (2010) In vitro stability of Cucumber mosaic virus nanoparticles carrying a Hepatitis C virus-derived epitope under simulated gastrointestinal conditions and in vivo efficacy of an edible vaccine. J Virol Methods 165:211–215
Taylor SL (2002) Protein allergenicity assessment of foods produced through agricultural biotechnology. Annu Rev Pharmacol Toxicol 42:99–112
Joensuu JJ, Kotiaho M, Riipi T et al (2004) Fimbrial subunit protein FaeG expressed in transgenic tobacco inhibits the binding of F4ac enterotoxigenic Escherichia coli to porcine enterocytes. Transgenic Res 13:295–298
Des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V (2006) Nanoparticles as potential oral delivery systems of protein and vaccines: a mechanistic approach. J Control Rel 116: 1–27
Puntoriero G, Meola A, Lahm A et al (1998) Towards a solution for Hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 17(13):3521–3533
Nuzzaci M, Piazzolla G, Vitti A et al (2007) Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope. Arch Virol 152:915–928
Lot H, Marrou J, Quiot JB, Esvan C (1972) Contribution a l’etude du virus de la mosaique du cocombre (CMV). I. Methode de purification rapide du virus. Ann Phytopathol 14: 25–38
Natilla A, Piazzolla G, Nuzzaci M et al (2004) Cucumber mosaic virus as carrier of a Hepatitis C virus-derived epitope. Arch Virol 149(1): 137–154
Vitti A, Piazzolla G, Condelli V et al (2010) Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer’s disease. J Virol Methods 69:332–340
Feng JL, Chen SN, Tang XS et al (2006) Quantitative determination of cucumber mosaic virus genome RNAs in virions by realtime transcription-polymerase chain reaction. Acta Biochim Biophys Sin 38:669–676
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Vitti, A., Nuzzaci, M., Condelli, V., Piazzolla, P. (2014). Simulated Digestion for Testing the Stability of Edible Vaccine Based on Cucumber mosaic virus (CMV) Chimeric Particle Display Hepatitis C virus (HCV) Peptide. In: Lin, B., Ratna, B. (eds) Virus Hybrids as Nanomaterials. Methods in Molecular Biology, vol 1108. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-751-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-62703-751-8_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-750-1
Online ISBN: 978-1-62703-751-8
eBook Packages: Springer Protocols